Literature DB >> 17846109

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline.

S L Miller1, E Fenstermacher, J Bates, D Blacker, R A Sperling, B C Dickerson.   

Abstract

OBJECTIVE: To use functional MRI (fMRI) to investigate whether hippocampal activation during a memory task can predict cognitive decline in individuals with mild cognitive impairment (MCI).
METHODS: 25 older individuals with MCI performed a visual scene encoding task during fMRI scanning, and were followed clinically for at least 4 years after scanning. A hypothesis driven analysis of fMRI data was performed. First, fMRI data were analysed at the group level to identify the regions of the hippocampal formation that were engaged by this memory task. Parameter estimates of each subject's memory related hippocampal activation (% signal change) were extracted and were analysed with a linear regression model to determine whether hippocampal activation predicted the degree or rate of cognitive decline, as measured by change in Clinical Dementia Rating Sum-of-Boxes (CDR-SB).
RESULTS: Over 5.9 (1.2) years of follow-up after scanning, subjects varied widely in degree and rate of cognitive decline (change in CDR-SB ranged from 0 to 6, and the rate ranged from 0 to 1 CDR-SB unit/year). Greater hippocampal activation predicted greater degree and rate of subsequent cognitive decline (p<0.05). This finding was present even after controlling for baseline degree of impairment (CDR-SB), age, education and hippocampal volume, as well as gender and apolipoprotein E status. In addition, an exploratory whole brain analysis produced convergent results, demonstrating that the hippocampal formation was the only brain region where activation predicted cognitive decline.
CONCLUSIONS: In individuals with MCI, greater memory task related hippocampal activation is predictive of a greater degree and rate of cognitive decline subsequent to scanning. fMRI may provide a physiological imaging biomarker useful for identifying the subgroup of MCI individuals at highest risk of cognitive decline for potential inclusion in disease modifying clinical trials.

Entities:  

Mesh:

Year:  2007        PMID: 17846109      PMCID: PMC2683145          DOI: 10.1136/jnnp.2007.124149

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  39 in total

1.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2005-11-09       Impact factor: 4.673

2.  Aging and the neural correlates of successful picture encoding: frontal activations compensate for decreased medial-temporal activity.

Authors:  Angela H Gutchess; Robert C Welsh; Trey Hedden; Ashley Bangert; Meredith Minear; Linda L Liu; Denise C Park
Journal:  J Cogn Neurosci       Date:  2005-01       Impact factor: 3.225

3.  Alzheimer neuropathology in nondemented aging: keeping mind over matter.

Authors:  Carol F Lippa; John C Morris
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.

Authors:  Martha Storandt; Elizabeth A Grant; J Philip Miller; John C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

5.  Neuropathology of older persons without cognitive impairment from two community-based studies.

Authors:  D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

6.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

7.  Risk factors for transitions from normal to mild cognitive impairment and dementia.

Authors:  R J Kryscio; F A Schmitt; J C Salazar; M S Mendiondo; W R Markesbery
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

8.  Memory complaints are related to Alzheimer disease pathology in older persons.

Authors:  L L Barnes; J A Schneider; P A Boyle; J L Bienias; D A Bennett
Journal:  Neurology       Date:  2006-11-14       Impact factor: 9.910

Review 9.  Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.

Authors:  Bradford C Dickerson; Reisa A Sperling
Journal:  NeuroRx       Date:  2005-04

10.  Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

Authors:  Deborah Blacker; Hang Lee; Alona Muzikansky; Emily C Martin; Rudolph Tanzi; John J McArdle; Mark Moss; Marilyn Albert
Journal:  Arch Neurol       Date:  2007-06
View more
  106 in total

Review 1.  Episodic memory on the path to Alzheimer's disease.

Authors:  Michela Gallagher; Ming Teng Koh
Journal:  Curr Opin Neurobiol       Date:  2011-11-11       Impact factor: 6.627

Review 2.  Potential of functional MRI as a biomarker in early Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

3.  Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.

Authors:  Deepti Putcha; Michael Brickhouse; Kelly O'Keefe; Caroline Sullivan; Dorene Rentz; Gad Marshall; Brad Dickerson; Reisa Sperling
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

4.  Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment.

Authors:  Ming Teng Koh; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

5.  Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders.

Authors:  J Carson Smith; Kristy A Nielson; John L Woodard; Michael Seidenberg; Sally Durgerian; Piero Antuono; Alissa M Butts; Nathan C Hantke; Melissa A Lancaster; Stephen M Rao
Journal:  Neuroimage       Date:  2010-08-05       Impact factor: 6.556

6.  Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults.

Authors:  Michael A Yassa; Joyce W Lacy; Shauna M Stark; Marilyn S Albert; Michela Gallagher; Craig E L Stark
Journal:  Hippocampus       Date:  2010-05-20       Impact factor: 3.899

Review 7.  Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Stephanie L Leal; Michael A Yassa
Journal:  Ageing Res Rev       Date:  2013-02-04       Impact factor: 10.895

Review 8.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

9.  fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults.

Authors:  Mehul A Trivedi; Christopher M Murphy; Celine Goetz; Raj C Shah; John D E Gabrieli; Susan Whitfield-Gabrieli; David A Turner; Glenn T Stebbins
Journal:  Dement Geriatr Cogn Disord       Date:  2008-07-28       Impact factor: 2.959

10.  Mild cognitive impairment: searching for the prodrome of Alzheimer's disease.

Authors:  Paul B Rosenberg; Constantine Lyketsos
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.